Skip to main content

Merton

Response to FOI (original text)

Your plans for meeting the NHS England Libre policy

In July 2018, FreeStyle Libre was approved for use in NHS Merton CCG. In developing this policy, the Regional Medicines Optimisation Committee (RMOC) - North statement was considered by NHS England London diabetes clinical networks (Clinical Leadership Group and Type 1 Diabetes Network). Additional advice was sought from members of the South East Coast and London and Young Peoples Diabetes Network for paediatric patients. These groups had representation from a variety of clinicians,commissioners and patient representatives.

On the 7th March 2019, NHS England published revised criteria for ‘Flash Glucose Monitoring: National Arrangement for Funding of Relevant Diabetes Patients’ publication’. NHS Merton CCG recognises that Flash Glucose Monitoring is a novel and innovative device and will now consider the recommendations in this document for the benefit of the patient group as specified.

How the Libre prescribing process will be handled? Will it be Red, Amber or Green listed?

NHS Merton CCG will seek guidance from NHS England London Diabetes Clinical Networks and NHSLondon Procurement Partnership (LPP) to ensure the new policy and implementation is adopted in a consistent manner to other CCGs in London. This will ensure equity of access for patients in NHS Merton CCG. The process of approval for this new policy will include involvement of local clinicians to facilitate implementation. In addition, we will follow our usual governance routes for getting policies approved by our local decision-making committees.

NHS Merton CCG does not operate a traffic light classification for medical devices or drugs. Once the policy is approved, clinicians will be able to prescribe the device in line with the approved policy.

Comments

Popular posts from this blog

Big Announcement - Libre Funding

NEWS RELEASE Embargoed 00:01 November 14 NHS TO PROVIDE LIFE CHANGING GLUCOSE MONITORS FOR TYPE 1 DIABETES PATIENTS Tens of thousands of people with Type 1 diabetes across the country will benefit from life changing glucose monitors on the NHS. To coincide with World Diabetes Day, Simon Stevens, Chief Executive of NHS England, is announcing action to end the current variation patients in some parts of the country are facing to access Freestyle Libre. The wearable sensor does away with the need for inconvenient and sometimes painful finger prick blood tests by relaying glucose levels to a smart phone or e-reader. NHS England will ensure the device, which is the size of a £2 coin and sits on the arm, is available on prescription for all patients who qualify for it in line with NHS clinical guidelines. From April 2019, these patients will be able to receive it on prescription from their local GP or diabetes team helping them to better manage their blood sugar levels. It comes as the NHS seeks t…

The CCG Project!

In order to find out the situation around the country for Libre prescribing now that the national policy has been published, I have made the decision to contact many of them to find out their plans.  I have arbitrarily chosen to contact all English CCGs that in December 2018 prescribed Libre via Primary Care to less than 5% of their population (and one specific request from a group member).  I had hoped this would be a small list, but there are 135 CCGs on the list.  I may have bitten off more than I can chew, but I'm committed to doing this and feeding back.  It worked before and hopefully this level of scrutiny will bring similar results.

Below is a screenshot of the base document I am sending to each of the CCGs - it has some fields that are merge fields, so don't worry about the brackets and codes in the document (I found a typo, which has now been corrected too)
The major piece of work with respect to this is finding the right person to contact.  However, I have some m…

NHS England Libre Policy

The NHS England policy for prescribing of Freestyle Libre has now been released.  There is a link to the document at the bottom of the page, but the key part of the policy can be viewed below.  Here is the Link to Policy